Valantine Hannah bought BBIO
June 22, 2026 · Form 4 insider transaction
Valantine Hannah bought 5,277 shares of BridgeBio Pharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,277
Price
$0.00
Total value
N/A
InsiderValantine Hannah
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 22, 2026
Filing dateJune 24, 2026
Shares owned after5,277
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares underlying the stock option vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date.